(Q51771677)
Statements
Capacity of the manufacturing process of Flebogamma(®) DIF, a new human high purity intravenous immunoglobulin, to remove a TSE model-agent. (English)
1 reference
José M Diez
1 reference
Santiago Caballero
1 reference
Francisco Belda
1 reference
Magdalena Otegui
1 reference
Rodrigo Gajardo
1 reference
Juan I Jorquera
1 reference
22 September 2010
1 reference
38
1 reference
6
1 reference
670-674
1 reference